#POLB featured in the Irish Times following the recently announced Option Agreement to licence #MelioVac with University College Dublin

• Potential to generate significant returns for investors
• Contributing to the global response to the threat of infectious diseases

https://www.irishtimes.com/business/health-pharma/poolbeg-pharma-agrees-option-agreement-with-ucd-1.4747770